Cristina Suárez

Home Tag

cristina saurez web 3

CALYPSO: combined MET and PD-L1 inhibition shows promise in a cohort of patients with MET-driven metastatic papillary renal cancer.

Results of the phase II single arm, multi-site international CALYPSO study point to the efficacy of combining potent MET inhibitor…

22_06_02_Cristina-Suarez_02

On the ground at ESMO Congress 2022: reporting on the promise of immunotherapy in kidney cancer

Presented at the 2022 annual Congress of the European Society for Medical Oncology (ESMO), results from three studies co-authored by…

Ok_elegida_por_ella

CheckMate 9ER: extended follow-up data further supports nivolumab plus cabozantinib as first-line treatment of advanced renal cell carcinoma

The phase III international CheckMate 9ER trial continues to make headlines. Now published ahead of print in The Lancet Oncology…

Ok_elegida_por_ella

VHIO co-led studies illuminate the value of biomarker analyses & point to a new treatment avenue for patients with renal cell carcinoma

Kidney cancer (KC) ranks 14th in the most common cancers with 431,288 cases in 2020 and an estimated 179,368 deaths…

ESMO

Newly appointed ESMO faculty: VHIO investigators join forces with other leading experts in oncology to deliver on ESMO’s Vision 2025

In parallel with the European Society for Medical Oncology’s (ESMO) publication of its 2025 Vision, which builds on the core…